🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214
This pilot study aims to explore whether a digital approach to managing chi...
Status
Recruiting
Location
Hôpital Necker Enfants Malades AP-HP
Start Date
2025-11-25
Trial ID
NCT06902766
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN...
Status
Completed
Location
Investigational Site Number 840047
Start Date
2015-04-27
Trial ID
NCT02414854
Primary Objective: * To evaluate the long-term safety and tolerability of ...
Status
Completed
Location
Arizona Allergy and Immunology Research- Site Number : 8400002
Start Date
2018-06-21
Trial ID
NCT03560466
This is a patient level randomized trial for teenagers and adults with asth...
Status
Completed
Location
DARTNet Insitute
Start Date
2024-02-01
Trial ID
NCT06272370
Treatments Being Tested
This is a randomised, active-comparator, open-label, parallel-group, multic...
Status
Completed
Location
Research Site
Start Date
2019-08-01
Trial ID
NCT03924635
Treatments Being Tested
This study is a multi-center randomized controlled trial of children with a...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-25
Trial ID
NCT06112405
Treatments Being Tested
While asthma therapy is becoming more individualized based on asthma phenot...
Status
Recruiting
Location
DARTNet Institute
Start Date
2025-08-01
Trial ID
NCT07052942
Treatments Being Tested
Primary Objective: To describe the long-term safety of dupilumab in treatm...
Status
Completed
Location
Investigational Site Number :840099
Start Date
2018-08-30
Trial ID
NCT03620747
Treatments Being Tested